Lite Strategy, Inc. (LON:0JW9)
1.150
+0.048 (4.36%)
Feb 12, 2026, 2:31 PM GMT
Lite Strategy Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
27.80M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | 65.30M | 16.48M | 33.76% |
| Jun 30, 2023 | 48.82M | 8.12M | 19.95% |
| Jun 30, 2022 | 40.70M | 5.90M | 16.96% |
| Jun 30, 2021 | 34.80M | 7.04M | 25.36% |
| Jun 30, 2020 | 27.76M | 22.84M | 464.72% |
| Jun 30, 2019 | 4.92M | 3.29M | 203.02% |
| Jun 30, 2018 | 1.62M | -21.63M | -93.02% |
| Jun 30, 2017 | 23.25M | - | - |
| Jun 30, 2016 | - | - | - |
| Jun 30, 2015 | - | - | - |
| Jun 30, 2014 | - | - | - |
| Jun 30, 2013 | - | - | - |
| Jun 30, 2012 | - | - | - |
| Jun 30, 2011 | - | - | - |
| Jun 30, 2010 | - | - | - |
| Jun 30, 2009 | - | - | - |
| Jun 30, 2008 | 674.00K | 29.00K | 4.50% |
| Jun 30, 2007 | 645.00K | 199.00K | 44.62% |
| Jun 30, 2006 | 446.00K | 138.00K | 44.81% |
| Jun 30, 2005 | 308.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Abingdon Health | 8.43M |
| Arecor Therapeutics | 5.06M |
| Renalytix | 2.19M |
| Aptamer Group | 1.20M |
Lite Strategy News
- 3 months ago - MEI Pharma GAAP EPS of -$0.12 - Seeking Alpha
- 5 months ago - MEIP Options Delisting Effective September 11th - GuruFocus
- 5 months ago - MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS' - Business Wire
- 6 months ago - Crypto hoarding brings a stock pop for small firms—and in some cases shows patterns of possible insider trading - Fortune
- 6 months ago - MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising - Business Wire
- 7 months ago - BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode - TheNewswire
- 7 months ago - MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
- 7 months ago - US Stocks Likely To Open Higher Despite Trump Administration's 'Hard Deadline' Warning For Tariffs — Verizon, Domino's Pizza Earnings In Focus - Benzinga